Pharmaceutical Process Scale-Up
Pharmaceutical Process Scale-Up, Second Edition
Oral Lipid Based Formulations Enhancing the Bioavailability of Poorly Water-Soluble Drugs
F13
2003
Nanoparticle technology for_drug_delivery
Toxicology in Drug Development Lynnda Reid, Ph.D. Pharmacology/Toxicology Reviewer Center for Drug Evaluation and Research (CDER) Rafael Ponce, Ph.D.,
Regulatory Issues. Introduction to the Regulatory Approval Process; Overview of the FDA Investigational New Drug Application (IND); Summary of regulations.
